Jane Street’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.6M Buy
741,669
+690,966
+1,363% +$48.1M 0.01% 1110
2025
Q4
$3.37M Sell
50,703
-831,748
-94% -$53.8M ﹤0.01% 3863
2025
Q3
$59.4M Buy
882,451
+755,928
+597% +$59.8M 0.01% 865
2025
Q2
$11M Sell
126,523
-182,736
-59% -$14.3M ﹤0.01% 2025
2025
Q1
$21.1M Sell
309,259
-5,418
-2% -$442K 0.01% 1237
2024
Q4
$24.5M Buy
314,677
+295,928
+1,578% +$21.9M 0.01% 1125
2024
Q3
$1.26M Sell
18,749
-158,012
-89% -$13M ﹤0.01% 5419
2024
Q2
$20M Sell
176,761
-755,076
-81% -$95.5M ﹤0.01% 1317
2024
Q1
$129M Buy
931,837
+485,090
+109% +$61M 0.03% 311
2023
Q4
$55.4M Buy
446,747
+295,509
+195% +$30.2M 0.01% 627
2023
Q3
$14.1M Sell
151,238
-20,633
-12% -$2.33M ﹤0.01% 1417
2023
Q2
$22.1M Buy
171,871
+137,072
+394% +$16.6M 0.01% 1122
2023
Q1
$4.04M Sell
34,799
-148,313
-81% -$16.6M ﹤0.01% 2738
2022
Q4
$20.7M Sell
183,112
-71,920
-28% -$7.9M 0.01% 978
2022
Q3
$20.5M Buy
255,032
+69,896
+38% +$5.92M 0.01% 1043
2022
Q2
$13.8M Sell
185,136
-85,452
-32% -$7.8M 0.01% 1429
2022
Q1
$34.6M Buy
270,588
+132,812
+96% +$14.5M 0.01% 884
2021
Q4
$18.5M Buy
137,776
+46,880
+52% +$6.74M 0.01% 1275
2021
Q3
$12.4M Sell
90,896
-50,600
-36% -$6.38M ﹤0.01% 1533
2021
Q2
$15.1M Buy
141,496
+41,952
+42% +$4.03M 0.01% 1319
2021
Q1
$8.94M Buy
99,544
+24,760
+33% +$2.32M ﹤0.01% 1669
2020
Q4
$6.91M Buy
74,784
+40,932
+121% +$3.65M ﹤0.01% 1740
2020
Q3
$3.49M Sell
33,852
-216,504
-86% -$22.6M ﹤0.01% 2255
2020
Q2
$25.4M Buy
250,356
+230,048
+1,133% +$20.6M 0.02% 637
2020
Q1
$1.37M Sell
20,308
-3,396
-14% -$211K ﹤0.01% 2435
2019
Q4
$1.3M Sell
23,704
-22,200
-48% -$1.05M ﹤0.01% 2437
2019
Q3
$1.71M Buy
+45,904
New +$1.78M ﹤0.01% 1972
2019
Q2
Sell
-74,716
Closed -$2.35M 5238
2019
Q1
$2.23M Buy
74,716
+41,600
+126% +$1.46M ﹤0.01% 1916
2018
Q4
$992K Sell
33,116
-20,608
-38% -$654K ﹤0.01% 2571
2018
Q3
$1.92M Buy
53,724
+41,584
+343% +$1.29M ﹤0.01% 1958
2018
Q2
$288K Sell
12,140
-5,932
-33% -$126K ﹤0.01% 4162
2018
Q1
$335K Sell
18,072
-147,824
-89% -$2.19M ﹤0.01% 3897
2017
Q4
$2.38M Buy
165,896
+95,348
+135% +$1.24M 0.01% 1437
2017
Q3
$863K Buy
70,548
+44,188
+168% +$781K ﹤0.01% 2451
2017
Q2
$482K Buy
+26,360
New +$487K ﹤0.01% 3085
2017
Q1
Sell
-195,920
Closed -$3.82M 4237
2016
Q4
$2.92M Buy
+195,920
New +$3.47M 0.01% 1009
2016
Q3
Sell
-73,536
Closed -$1.64M 4087
2016
Q2
$1.46M Buy
73,536
+32,500
+79% +$553K 0.01% 1581
2016
Q1
$697K Buy
41,036
+12,912
+46% +$216K ﹤0.01% 2236
2015
Q4
$576K Sell
28,124
-55,976
-67% -$1.16M ﹤0.01% 2328
2015
Q3
$1.8M Sell
84,100
-5,540
-6% -$124K 0.01% 1092
2015
Q2
$1.79M Buy
+89,640
New +$1.57M 0.01% 1078
2015
Q1
Sell
-15,448
Closed -$213K 3166
2014
Q4
$213K Buy
+15,448
New +$189K ﹤0.01% 2168
2014
Q2
Sell
-54,388
Closed -$563K 2663
2014
Q1
$563K Buy
+54,388
New +$562K 0.01% 1453
2013
Q3
Sell
-68,656
Closed -$385K 2781
2013
Q2
$385K Buy
+68,656
New +$329K 0.01% 1669

Other funds holding DXCM

Jane Street's DXCM Position: Q1 2026 in Review

Jane Street increased its DexCom (DXCM) stake by 1,363% in Q1 2026, buying an estimated $48.1M and bringing the position to 741,669 shares worth $46.6M. The position accounts for 0.01% of the portfolio, ranked #1110.

Jane Street first reported a position in DXCM in Q2 2013 and has held it in 44 quarters since. The position peaked at $129M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Jane Street held 741,669 shares of DexCom worth $46.6M as of Q1 2026.
  • Jane Street bought 690,966 DexCom shares in Q1 2026, an estimated $48.1M.
  • DexCom made up 0.01% of Jane Street's portfolio in Q1 2026, its #1110 holding.
  • Jane Street first reported a position in DexCom in Q2 2013 and has held it in 44 quarters since.
  • Jane Street's DexCom position peaked at $129M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.